Prostate and bladder cancer
- Introduction: Prostate and bladder cancer
- Screening for prostate cancer
- The management of high risk localised prostate cancer
- Surgical and oncological outcomes following cystectomy for transitional cell cancer
- Techniques for bladder preservation for muscle invasive bladder cancer
- Novel biomarkers and therapeutics for castration-resistant prostate cancer
- FGFR3 mutation is not the initiating mutation in urothelial cell cancer
- Identification of multiple genetic variants which predispose to prostate cancer by genome-wide association in the PRACTICAL international consortium
